Antihormonal to Leukemia--Modified Cytokine Receptor

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$692,768.00
Award Year:
1995
Program:
SBIR
Phase:
Phase II
Contract:
1 R43 CA63861-1,
Award Id:
24863
Agency Tracking Number:
24863
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
4853 Cordell Avenue #1407, Bethesda, MD, 20814
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
David Hankins
(301) 652-2130
Business Contact:
() -
Research Institution:
n/a
Abstract
This Phase I is designed to test feasibility of developing immunotoxins for human lymphoidleukemia using IL-2 and either 90Y or 131I. There is ample evidence that many cases of humanleukemia are cytokine-dependent. The Principal Investigator has long experience in the study oferythropoietin-dependent erythroleukemia induced by Friend's spleen focus forming virus. Recently,several clinical trials have already established the efficacy of immunotoxin approach in certainmalignancies and other diverse conditions such as autoimmune disorders and graft vs. host diseases.In this application, we will test bioactivity of human recombinant prepare and purify 131I-IL-2, prepareand purify 90Y-IL-2, analyze the radiolabeled IL-2 compounds and test specificity of the compoundsusing cell lines that are dependent on other cytokines. We will also test the effects on primary murineand human T-cells.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government